Effect of the meglitinide analog S21403 on cationic fluxes and insulin release in perifused rat pancreatic islets exposed to a high concentration of D-glucose
K. Louchami et al., Effect of the meglitinide analog S21403 on cationic fluxes and insulin release in perifused rat pancreatic islets exposed to a high concentration of D-glucose, PHARMAC RES, 40(3), 1999, pp. 297-300
The effect of the meglitinide analog S21403 (10 mu M) upon Rb-86 and Ca-45
outflow and insulin release was investigated in perifused rat islets expose
d to a high concentration of D-glucose (16.7 mM) in order to simulate the s
ituation found in diabetic patients. Under these conditions, S21403 provoke
d a rapid, sustained and rapidly reversible increase in Rb-86 outflow, Ca-4
5 efflux and insulin release. These effects were suppressed or reversed whe
n the experiments were conducted in the absence of extracellular Ca2+. They
support the view that S21043 could be used as a novel insulinotropic tool
in the treatment of non-insulin-dependent diabetes mellitus, the cationic a
nd secretory responses to the drug displaying a favourable time course for
prompt and not unduly prolonged activation of islet B-cells. (C) 1999 Acade
mic Press.